TITLE

1 of 2 quality-improvement interventions for depression in managed care was more effective but more costly than usual care

AUTHOR(S)
Diemer, Margretta; Hatzigeorgiou, Christos
PUB. DATE
May 2002
SOURCE
ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p116
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on a study which examined cost-effectiveness of practice-initiated quality improvement for depression. Outcome measures; Criticism on the standard interventions for patients with depression.
ACCESSION #
8856117

 

Related Articles

  • Cost-Effectiveness Analysis of Pharmaceutical Treatment Options in the First-Line Management of Major Depressive Disorder in Belgium. Annemans, Lieven; Brignone, Mélanie; Druais, Sylvain; Pauw, Ann; Gauthier, Aline; Demyttenaere, Koen // PharmacoEconomics;May2014, Vol. 32 Issue 5, p479 

    Objective: The objective of this study was to assess the cost effectiveness of commonly used antidepressants as first-line treatment of major depressive disorder (MDD) in Belgium. Methods: The model structure was based on a decision tree developed by the Swedish TLV (Tandvårds- och...

  • Not all patients who have depression are treated equal. Petersen, Carolyn // Managed Healthcare;Aug99, Vol. 9 Issue 8, p42 

    Examines the costs of treating depression in the United States. Economic estimates on depression treatment; Management of the cost of antidepression drugs by health care plans; Results of studies on antidepressant usage patterns; Types of patients receiving antidepressant medications. INSET:...

  • THE PRICE is right.  // Marketing Health Services;Fall2002, Vol. 22 Issue 3, p6 

    This article reports on a study of antidepressant drugs published in "Clinical Therapeutics." The study revealed that antidepressants offer significant savings to patients because it can help alleviate some of the most serious symptoms of depression. Over a two-year period, researcher Douglas...

  • Depressed and/or SA patients use more health care than general population.  // Outcomes & Accountability Alert;Jun99, Vol. 4 Issue 6, p10 

    Presents information on a study on the costs of medical treatment for depression and substance abuse in the United States, using data from the 1994 National Health Interview Survey. How the study was conducted; Findings; Conclusions.

  • The value of mental health care at the system level: The case of treating depression. Frank, Richard G.; McGuire, Thomas G. // Health Affairs;Sep/Oct1999, Vol. 18 Issue 5, p71 

    Proposes the systems cost-effectiveness (SCE) method for assessing the value of mental health care delivery system in the United States. Application of the SCE method to acute-phase treatment of depression; Approaches for defining value of mental health care; Factors considered in the assessing...

  • Depression in the workplace: Effects on short-term disability. Kessler, Ronald C.; Barber, Catherine // Health Affairs;Sep/Oct1999, Vol. 18 Issue 5, p163 

    Examines the effects of employee depression treatment on short-term work disability in the United States. Association between indirect salary-equivalent cost of disability and cost of depression treatment; Effect of employee depression treatment on company productivity gains; Comparison of...

  • Organized Care for Depression Improves Outcomes and Reduces Costs. Pignone, Michael // Clinical Diabetes;Winter2008, Vol. 26 Issue 1, p15 

    The article discusses research being done on the cost-effectiveness of systematic depression treatment among people with diabetes mellitus. It references a study by G. E. Simon, W. J. Katon et al., published in the 2007 issue of "Archives of General Psychiatry." Simon et al at Group Health...

  • Treatment-resistant depression increases health costs and resource utilization. Lepine, Beatrice Alinka; Moreno, Ricardo Alberto; Campos, Rodolfo Nunes; Couttolenc, Bernard Francois // Revista Brasileira de Psiquiatria;dec2012, Vol. 34 Issue 4, p379 

    Objective: Major Depressive Disorder (MDD) is a debilitating condition with a marked social impact. The impact of MDD and Treatment-Resistant Depression (TRD+) within the Brazilian health system is largely unknown. The goal of this study was to compare resource utilization and costs of care for...

  • FROM EMPLOYERS TO PAYERS TO PLANS TO PATIENTS: How to Improve Treatment Outcomes for Depression Through Collaboration of Care. Craynor, William; Lavin, Marjorie // Formulary;Sep2006 Supplement, Vol. 41, p3 

    The article focuses on the improvement of health care plans to cover depression treatment cost for employees in the U.S. Employers have been effected by employees who suffered from depression because it could significantly affect financial drain through absenteeism and lost of productivity....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics